Castle Biosciences CSTL Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Castle Biosciences’s reported figures.
Based on trailing twelve months.
The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Castle Biosciences's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Castle Biosciences's operating margin?
- Castle Biosciences (CSTL) reported operating margin of -9.8% in Q1 2026.
- How has Castle Biosciences's operating margin changed year-over-year?
- Castle Biosciences's operating margin decreased by 146.5% year-over-year, from -4% to -9.8%.
- What is the long-term trend for Castle Biosciences's operating margin?
- Over 5 years (2020 to 2025), Castle Biosciences's operating margin has grown at a 3.6% compound annual growth rate (CAGR), from -10.4% to -12.4%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.